Hirohiko Shibayama

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Genetic Variants in C5 and Poor Response to Eculizumab

Jun‐ichi Nishimura, Masaki Yamamoto, Shin Hayashi et al. · New England Journal of Medicine · 2014 · 392 citations · Full text

Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells

Yusuke Satoh, Itaru Matsumura, Hirokazu Tanaka et al. · Journal of Biological Chemistry · 2004 · 160 citations · Full text

Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability

Charlie Mantel, Ying Guo, Man Ryul Lee et al. · Blood · 2007 · 140 citations · Full text

Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis

Hirohiko Shibayama, Emi Takai, Itaru Matsumura et al. · The Journal of Experimental Medicine · 2004 · 119 citations · Full text